In the world of transplant contracting, there is much attention paid to case rates, stop-loss provisions and the various tiers of inlier and outlier payment percentages. This webinar will highlight an often overlooked yet crucial factor: acquisition charges. These charges play a vital role in determining the success of a contract and can make or break a deal. We will delve into the many costs involved in acquiring bone marrow and solid organs as well as preservation of solid organs. Key topics will include changes in allocation policies, advancements in preservation technology, and their impact on organ acquisition costs. Additionally, we will discuss how standard acquisition costs are calculated and integrated into contract pricing.

Gene and Cell Therapies are ushering in a new era of treatment for complex and previously untreatable conditions. As these therapies move from controlled clinical trial environments into real-world practice, they present both groundbreaking opportunities and pressing challenges across the healthcare system. This webinar will provide a comprehensive overview of the current gene and cell therapy pipeline—from investigational development through FDA approval to real-world application—with particular focus on the critical transition into standard care.

An insightful webinar featuring experts from the University Health Transplant Institute as they explore the key elements of a high-performing transplant program and share practical strategies to increase living donation.

Presented by Dr. Ashish Garg, MD, Attending Physician in Cardiology at Ann & Robert H. Lurie Children's Hospital of Chicago and Assistant Professor of Pediatrics (Cardiology) at Northwestern University Feinberg School of Medicine. Dr. Garg will share insights on the evolving landscape of pediatric Ventricular Assist Device (VAD) support. Pediatric heart failure remains a critical and complex clinical challenge, with heart transplantation serving as the definitive therapy for many children with end-stage disease. However, the limited availability of donor organs necessitates the use of ventricular assist devices (VADs) as a bridge to transplant in select pediatric patients. Over the past two decades, advances in technology, patient selection strategies, and perioperative management have significantly expanded the role of pediatric VADs.